LUMINOS-103: A Basket Trial of Safety & Efficacy of Lerapolturev With or Without Checkpoint Inhibitors

PHASE1/PHASE2TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

April 4, 2024

Study Completion Date

June 12, 2024

Conditions

Solid TumorBladder CancerNon-muscle-invasive Bladder Cancer

Interventions

BIOLOGICAL

Lerapolturev

Lerapolturev administered via intravesical instillation once

OTHER

5% DDM

5% DDM and saline washes

Trial Locations (1)

Carolina Urologic Research Center, Myrtle Beach